Charles Market Capitalization from 2010 to 2024

CRL Stock  USD 194.19  6.29  3.35%   
Charles River Market Cap yearly trend continues to be quite stable with very little volatility. Market Cap may rise above about 1.9 B this year.
Check Charles River financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Charles River's main balance sheet or income statement drivers, such as Depreciation And Amortization of 329.8 M, Interest Expense of 143.5 M or Selling General Administrative of 787.9 M, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 9.0E-4 or PTB Ratio of 2.7. Charles financial statements analysis is a perfect complement when working with Charles River Valuation or Volatility modules.
  
Check out the analysis of Charles River Correlation against competitors.

Latest Charles River's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Charles River Laboratories over the last few years. It is Charles River's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Charles River's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 9.61 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Charles Market Capitalization Regression Statistics

Arithmetic Mean1,687,978,380
Geometric Mean1,612,876,347
Coefficient Of Variation35.18
Mean Deviation457,029,890
Median1,388,994,312
Standard Deviation593,828,014
Sample Variance352631.7T
Range1.7B
R-Value(0.49)
Mean Square Error287292.2T
R-Squared0.24
Significance0.06
Slope(65,521,126)
Total Sum of Squares4936844T

Charles Market Capitalization History

20241.9 B
20231.3 B
2012B
20111.4 B
20102.3 B

About Charles River Financial Statements

Charles River investors utilize fundamental indicators, such as Market Capitalization, to predict how Charles Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts. Charles River operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18600 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports:
Check out the analysis of Charles River Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.21)
Earnings Share
8.08
Revenue Per Share
78.97
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0487
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.